Najít Technologies, Inc. (NTI) is structured around development of safe and effective vaccines for emerging and re-emerging infectious diseases. With primary emphasis is on engaging the firms proprietary vaccine technology to benefit underserved and vulnerable populations, such as the very young, the elderly, and the immune-compromised, The firms vaccine platform offers increased safety and immunogenicity. Strategy is to develop vaccines that fit the unmet needs of these market segments in addition to military and civilian travelers who need safe but highly effective vaccines against potentially life - threatening infectious diseases in endemic countries.
